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Figure 1. Ultrasonography scan of 62-year-old female (case 1) 
showeda a cystic mass in right lobe peripheral area. It had 
irregular margin and peripheral septa-like structures.
INTRODUCTION
Biliary hamartoma or bile duct hamartoma is a rare 
benign hepatic lesion. It is also known as von Meyenburg 
complex, and is one of ductal plate malformation in adults.
1 
Pathologically, biliary hamartoma is composed of disorganized 
bile ducts and ductules and fibrocollagenous stroma.
2 Biliary 
hamartoma usually presents as multiple small nodules.
1-4 
But in case of single or large hamartoma, its radiological 
diagnosis is very difficult, and the lesion is confused with 
metastasis or abscess. So histopahologic examination is 
required for final diagnosis. 
In this report, two cases of biliary hamartomas that 
manifested as a single lesion making their pre-operative 
diagnosis difficult are presented. 
CASE
Case 1
A 62-year-old female was admitted to hospital for the 
evaluation of incidentally detected hepatic lesion. She took 
health examination at local hospital, and a hepatic mass 
was detected on ultrasonography (US). She did not present 
specific symptoms such as abdominal pain or anorexia. 
Physical examination revealed no specific findings such as 
hepatomegaly.
The laboratory findings did not show abnormal finding. 
Hematologic study showed red blood cell (RBC) count of 
4.7×10
6 /mm
3, hemoglobin level of 14.3 g/dL, and hematocrit 
of 42.1%. White blood cell (WBC) count was 5,100/mm
3 
and platelet count was 228,000/mm
3. Biochemical tests 
showed that the serum level of alanine aminotransferase 
(ALT) was 22 IU/L, aspartate aminotransferase (AST) was 
15 IU/L, and alkaline phosphatase (ALP) was 85 IU/L. 
Serum protein was 7.6 g/dL and albumin was 4.8 g/dL. Total 
bilirubin was 0.9 mg/dL. Alpha-fetoprotein (AFP) was 1.6 
ng/mL, and carcinoembryonic antigen (CEA) was 2.5 ng/mL. 
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Figure 3. Ultrasonography scan of 79-year-old male (case 2) 
showed a 1cm-sized round echogenic mass in liver subcapsular 
area (arrow).
   
Figure 2. Dynamic CT scans of the above patient. (A) Precontrast scan showed homogenous low-attenuated mass in liver dome 
peripheral area. (B) Arterial phase and (C) portal phase of CT scan. After contrast enhancement, there was no enhancing portion of 
the lesion.
negative and anti-HBs was positive.
US showed about a 4-cm sized cystic liver mass in right 
lobe (Fig. 1). It showed irregular margin with internally 
homogenous fluid-like echo with several peripheral echogenic 
septa-like structures. Precontrast computed tomography (CT) 
scan showed a lobulating contoured homogenous low 
attenuated mass in right lobe posterior superior segment. 
The attenuation was measured as about 10 Hounsfield number 
that indicated clear fluid. After contrast media injection, 
arterial phase and portal phase images were taken, and there 
was no contrast enhancement in the mass (Fig. 2A, 2B). 
Radiological diagnosis was biliary cystadenoma or cystadeno-
carcinoma. So operation was done. Pathologic specimen 
showed a subcapsular multilocular cystic mass. Final histo-
pathologic diagnosis was biliary hamartoma with cystic 
dilatation. 
Case 2
A 79-year-old male was admitted with the complaint of 
bowel habit change. Sigmoidoscopy revealed a fungating 
mass at 20 cm above anal verge. Biopsy was done and the 
mass was confirmed as mucinous adenocarcinoma. He had 
lost 3 Kg weight during 2 months. Physical examination 
revealed no specific findings such as hepatomegaly. 
The laboratory findings showed RBC count of 3.7×10
6/mm
3, 
hemoglobin level of 11.0 g/dL, and hematocrit of 33.9%. 
WBC count was 7,100/mm
3 and platelet count was 178,000/mm
3. 
Biochemical tests showed that the serum level of ALT was 
10 IU/L, AST was 12 IU/L, and ALP was 86 IU/L. Serum 
protein was 7.3 g/dL and albumin was 3.7 g/dL. Total 
bilirubin was 0.7 mg/dL. AFP was not evaluated, and CEA 
was 1.7 ng/mL. The results for HBsAg and anti-HBs were 
negative.
For staging work up, US and CT scan were done. US 
showed a 1 cm-sized echogenic mass in right lobe anterior- 
inferior segment (Segment V) (Fig. 3). CT scan showed an 
ulcerofungating mass in sigmoid colon and several enlarged 
lymph nodes in mesosigmoid. The Liver nodule was 
presented as 1 cm sized, ill-defined low attenuated nodule in 
hepatic subcapsular area of segment V. The nodule showed 
peripheral subtle rim-like enhancement (Fig. 4). So it was 
suspected as hepatic metastasis. 
Magnetic resonance imaging (MRI) was taken (Fig. 5). 
The hepatic nodule showed low signal intensity on T1-weighted 
image, and high signal intensities on T2-weighted image and 
diffusion image. After contrast enhancement with Gadoxetic 
acid (gadolinium-EOB-DTPA, Primovist, Bayer-Schering, 
Berlin, Germany), it showed subtle rim-like enhancement. 
On hepatobiliary phase, and it showed hypointensity. 
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Figure 5. MRI scans. (A) T1 weighted image 
showed low signal intensity nodule in 
segment V (arrow). (B) On T2 weighted image, 
the nodule showed high signal intensity 
(arrow). (C) Enhanced image after 50 seconds 
after contrast media injection, and (D) enhanced 
scan after 3 minutes. The nodule showed subtle
peripheral enhancement (arrow). (E) On hepato-
biliary phase, the nodule presented as hypoin-
tensity lesion in liver (arrow).
Figure 4. CT scan presented the low attenuated nodule in liver. 
It showed subtle peripheral rim-like enhancement (arrow).
Differential radiological diagnosis included the possibilities 
of metastasis or atypical hemangioma. Fluorodeoxyglucose 
positron emission tomography (FDG-PET) scan showed no 
hypermetabolic lesion in right lobe of liver. 
Anterior resection for sigmoid colon cancer was done, 
and tumorectomy was also done for hepatic nodule. The 
hepatic mass was well-demarcated, pinkish white solid mass 
without necrosis or hemorrhage. Histopathologic diagnosis 
was bile duct hamartoma.
DISCUSSION
The biliary hamartoma is a rare hepatic lesion described 
for the first time in 1918 by Von Meyenburg.
1 It is consistent 
with biliary duct deformity and disorganization, forming 
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cystic structures varying in sizes.
3 It is hepatic malformations 
hypothesized to be a consequence of interrupted remodelling 
of the ductal plates during the late phase of embryologic 
development of the small intra-hepatic bile ducts.
5 Histologically, 
they demonstrate focal disorderly collections of dilated 
intra-hepatic bile ducts, which are lined by a single layer of 
columnar, cuboidal, or flattened epithelium, embedded 
within a dense fibrous stroma.
1 Its incidence is known as 
0.69%.
6 Biliary hamartoma is benign asymptomatic lesion 
without clinical significance, but malignant change to cholan-
giocarcinoma is also reported.
7,8
Biliary hamartoma is usually multiple and small well- 
circumscribed nodules ranging from 1 mm to 1.5 cm. But in 
some cases, it may presents as a single mass or coalescent 
large mass. Radiologically it can present from single well- 
circumscribed small nodule to numerous nodules evenly 
scattered in liver parenchyma, or large nonspecific mass. 
However, usual biliary hamartoma presents as hamartomatosis 
with numerous nodules. US shows numerous echogenic or 
hypoechoic nodules in liver and the nodules can accompany 
comet tail artifact.
4 When the nodules are innumerable, 
those heterogenous tiny nodules can mimic chronic hepatitis. 
Differences in echogenicity of each nodule may be due to 
the size of the dilated bile duct component, which, at a 
certain size, would behave like other microcystic structures 
and demonstrate echogenicity.
1
CT demonstrates multiple small hypoattenuated nodules 
that scattered in whole liver parenchyma. Usually tiny 
nodules do not present contrast enhancement. But in some 
large nodules with abundant fibrous stroma, it can show 
contrast enhancement. On MRI, the nodules show low signal 
intensity on T1-weighted images, and high signal intensity 
on T2 weighted image.
1,9 High signal intensity on T2-weighted 
image is due to cystic nature of the lesion, and numerous 
nodules in liver makes so-called “starry sky appearance” on 
T2-weighted image with multiple high signal intensity spots 
on dark background liver parenchyma. On MR cholangio-
pancreatography, the lesions do not demonstrate commu-
nications with bile duct, and bile duct shows normal 
appearance.
4,9 After contrast enhancement, the lesions usually 
do not show enhancement, but sometimes it may demonstrate 
thin rim enhancement with gadolinium. This is considered 
due to the compressed liver parenchyma that surrounds the 
lesions and inflammatory cell infiltrates at histological analysis.
9 
The practical problem of biliary hamartoma is that multiple 
hamartomas can be confused with metastasis, microabscess, 
simple cysts and even lymphoma. MRI can help to 
differentiate with metastasis. On heavily T2 weighted 
image, hamartomas show still bright high signal intensity 
unlike metastasis. Because of higher tissue contrast resolution 
of MRI than CT, MRI can demonstrate tiny nodules with 
high signal intensity on T2 weighted image better than CT. 
Consequently, the lesions can be manifested as “starry sky” 
appearance in the case of usual numerous hamartomatosis. 
So, most of biliary hamartomatosis does not require pathological 
confirmation nowadays when it presents typical radiological 
appearance. But, when the lesion presents peripheral 
enhancement like the case 2, or when the lesion presents a 
large single lesion like the case 1, it can cause diagnostic 
confusion even with MRI. It is true especially when the 
patient have another known malignancy. In those atypical 
cases such as single or enhancing lesion, pathological 
confirmation may be required for final diagnosis. 
SUMMARY
Usual biliary hamartomatosis presents as numerous small, 
non-enhancing nodules in liver. However, in some cases, it 
can presents as a single solid or cystic mass with various 
contrast enhancement pattern.
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